Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease
Status:
Completed
Trial end date:
2018-08-13
Target enrollment:
Participant gender:
Summary
The purpose of this study in healthy adult males is to investigate safety and
pharmacokinetics of single and multiple oral doses of KDT-3594.
The purpose of this study in patients with Parkinson's disease is to investigate safety and
pharmacokinetics of single and multiple oral doses of KDT-3594. The exploratory efficacy of
KDT-3594 will also be investigated.